|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06955 BOAN BIOTECH
Nominal 
6.980 +0.130 (+1.898%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -- | 2.829% | -5.275% | -15.397% | -14.955% |
| ROAE (%) | -- | 4.939% | -8.719% | -22.340% | -22.173% |
| Return on Capital Employed (%) | -- | 3.323% | -7.148% | -19.166% | -12.210% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | -- | 74.713% | 66.162% | 68.655% | 67.115% |
| EBITDA Margin (%) | -- | 24.554% | -3.831% | -48.662% | -108.951% |
| Pre-tax Profit Margin (%) | -- | 10.077% | -19.313% | -64.297% | -142.036% |
| Net Profit Margin (%) | -- | 10.077% | -19.313% | -64.297% | -142.036% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | -- | 1.474 X | 1.091 X | 1.795 X | 3.608 X |
| Quick Ratio (X) | -- | 1.215 X | 0.838 X | 1.491 X | 3.229 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | -- | 42.341% | 43.192% | 35.603% | 26.342% |
| Total Debt / Total Assets (%) | -- | 24.043% | 17.470% | 13.699% | 12.557% |
| Net Debt / Total Assets (%) | -- | 17.068% | 8.783% | 3.098% | -12.683% |
| Total Debt / Shareholders' Funds (%) | -- | 41.698% | 30.753% | 21.272% | 17.047% |
| Long Term Debt / Shareholders' Funds (%) | -- | 26.137% | 17.767% | 14.806% | 15.757% |
| Net Debt / Shareholders' Funds (%) | -- | 29.602% | 15.460% | 4.810% | -17.219% |
| Net Cash / (Debt) ($) | -- | (486.672M) | (204.055M) | (68.225M) | 267.180M |
| Net Cash / (Debt) per share ($) | -- | (0.908) | (0.401) | (0.134) | -- |
| Total Debt / Capital Employed (%) | -- | 31.124% | 24.305% | 17.432% | 14.329% |
| Interest Coverage Ratio (X) | -- | 3.242 X | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | -- | 331.430 Day | 269.547 Day | 273.613 Day | 414.417 Day |
| Receivables Turnover (Day) | -- | 183.375 Day | 144.174 Day | 112.972 Day | 124.156 Day |
| Payables Turnover (Day) | -- | 108.338 Day | 111.536 Day | 105.730 Day | 264.830 Day |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 7,144 |
| %Change | -90.239% |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB -- |